Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
Precision medicine aims to implement strategies based on the molecular features of tumors and optimized drug delivery to improve cancer diagnosis and treatment. DNA replication is a logical approach because it can be targeted by a broad range of anticancer drugs that are both clinically approved and...
Main Authors: | Ukhyun Jo, Yasuhisa Murai, Naoko Takebe, Anish Thomas, Yves Pommier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4601 |
Similar Items
-
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors
by: Sukhbir Kaur, et al.
Published: (2019-10-01) -
Schlafens: Emerging Proteins in Cancer Cell Biology
by: Sarmad Al-Marsoummi, et al.
Published: (2021-08-01) -
Schlafens Can Put Viruses to Sleep
by: Eui Tae Kim, et al.
Published: (2022-02-01) -
Common Chemical Inductors of Replication Stress: Focus on Cell‐Based Studies
by: Eva Vesela, et al.
Published: (2017-02-01) -
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathway
by: Yasuhisa Murai, et al.
Published: (2021-10-01)